| Zugriffe | |
|---|---|
| A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis | 173 |
| Oktober 2025 | November 2025 | Dezember 2025 | Januar 2026 | Februar 2026 | März 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis | 23 | 4 | 3 | 22 | 4 | 8 | 10 |
| Zugriffe | |
|---|---|
| 2020_Burmester_etal.pdf | 167 |
